Efficacy of the first infliximab administration influences long-term prognosis in refractory ulcerative colitis

被引:0
|
作者
Tanaka, H. [1 ]
Motoya, S. [1 ]
Yamashita, M. [1 ]
Imamura, A. [1 ]
机构
[1] Sapporo Kosei Gen Hosp, Inflammatory Bowel Dis Ctr, Sapporo, Hokkaido, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:111 / 112
页数:2
相关论文
共 50 条
  • [41] A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
    Arias, Maria Theresa
    Casteele, Niels Vande
    Vermeire, Severine
    van Overstraeten, Anthony de Buck
    Billiet, Thomas
    Baert, Filip
    Wolthuis, Albert
    Van Assche, Gert
    Noman, Maja
    Hoffman, Ilse
    D'Hoore, Andre
    Gils, Ann
    Rutgeerts, Paul
    Ferrante, Marc
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (03) : 531 - 538
  • [42] Infliximab and refractory ulcerative colitis Reply
    Ferrante, Marc
    Vermeire, Severine
    Van Assche, Gert
    Rutgeerts, Paul
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (01): : 45 - 45
  • [43] Infliximab for patients with refractory ulcerative colitis
    Chey, WY
    INFLAMMATORY BOWEL DISEASES, 2001, 7 : S30 - S33
  • [44] Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis
    Iborra, Marisa
    Alvarez-Sotomayor, Diego
    Nos, Pilar
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 39 - 46
  • [45] Long-Term Efficacy of Vedolizumab Therapy for Patients With Ulcerative Colitis
    Feagan, Brian
    Kaser, Arthur
    Smyth, Michael
    Panaccione, Remo
    Sankoh, Serap
    Abhyankar, Brihad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S477 - S478
  • [46] MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY OF LONG-TERM TREATMENT
    Petrolati, A.
    Nasoni, S.
    Altavilla, N.
    Cipolla, R.
    Fenderico, P.
    Forlini, G.
    Rossi, Z.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S134 - S134
  • [47] Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
    Yamamoto, S.
    Nakase, H.
    Mikami, S.
    Inoue, S.
    Yoshino, T.
    Takeda, Y.
    Kasahara, K.
    Ueno, S.
    Uza, N.
    Kitamura, H.
    Tamaki, H.
    Matsuura, M.
    Inui, K.
    Chiba, T.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (05) : 589 - 597
  • [48] Long term efficacy of oral microemulsion cyclosporin (Neoral") for refractory ulcerative colitis
    Actis, GC
    Rizzetto, M
    GASTROENTEROLOGY, 2002, 122 (04) : A433 - A433
  • [49] Efficacy of infliximab treatment for refractory ulcerative colitis and related prognostic factors
    Motoya, Satoshi
    Yamashita, Masaki
    Nasuno, Masanao
    Ishii, Manabu
    Tanaka, Hiroki
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 134 - 134
  • [50] Long-term outcomes in a cohort of patients with acute severe ulcerative colitis refractory to intravenous steroids treated with cyclosporine or infliximab
    Laharie, D.
    Bourreille, A.
    Branche, J.
    Allez, M.
    Bouhnik, Y.
    Filippi, J.
    Zerbib, F.
    Savoye, G.
    Vuitton, L.
    Moreau, J.
    Amiot, A.
    Cosnes, J.
    Ricart, E.
    Dewit, O.
    Lopez-Sanroman, A.
    Dupas, J. -L.
    Carbonnel, F.
    Bommelaer, G.
    Coffin, B.
    Roblin, X.
    Van Assche, G.
    Esteve, M.
    Farkkila, M.
    Gisbert, J. P.
    Marteau, P.
    Nahon, S.
    de Vos, M.
    Mary, J. -Y.
    Louis, E.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S10 - S11